Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for preventing or treating sepsis or septic shock comprising adk protein as active ingredient

a technology for sepsis or septic shock and active ingredients, which is applied in the direction of peptide/protein ingredients, antibacterial agents, transferases, etc., can solve the problems of sepsis, severe disease, and infection throughout the whole body, and achieve excellent therapeutic effects, inhibit binding effect, and enhance viability

Inactive Publication Date: 2016-09-15
KONKUK UNIV GLOCAL IND ACADEMIC COLLABORATION FOUND
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a protein called ADK, which is derived from a type of bacteria called Mycobacterium tuberculosis. This protein can stop the bacteria from attaching to cells in the body, and has been found to be effective in treating sepsis and septic shock in animal models. It is also able to improve the survival rate and reduce inflammation and cell death in the lungs and spleen.

Problems solved by technology

Sepsis is an inflammatory response induced as a lipopolysaccharide (LPS) that is an ingredient of a cell wall acts as a toxin to activate the immune system in a living body excessively when the living body is infected with pathogenic gram-negative bacteria, and causes infections throughout the whole body or is often accompanied by shock when its symptoms are severe.
Sepsis is a primary cause of death of hospital patients in the intensive care unit (ICU), and is a very serious disease since its mortality usually amounts to 30% or more.
In spite of the development of medical technology, the patients are often infected from the aftereffect following the surgery, and still develop sepsis all over the world.
Also, when peoples, such as newborn infants or the aged, which have weaker immune systems in the body, become infected, they often develop into sepsis.
However, when pathogens grow highly due to the delay of proper treatment or when a patient is infected with a strain strongly resistant to the antibiotic, the effective treatment cannot be achieved using only the antibiotic.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for preventing or treating sepsis or septic shock comprising adk protein as active ingredient
  • Composition for preventing or treating sepsis or septic shock comprising adk protein as active ingredient
  • Composition for preventing or treating sepsis or septic shock comprising adk protein as active ingredient

Examples

Experimental program
Comparison scheme
Effect test

example 1

Isolation of Dendritic Cells and Cloning of Recombinant ADK

[0043]1.1 Isolation and Induction of Dendritic Cells

[0044]Femoral bone marrow was extracted from 6- to 8-week old C57BL / 6 mice using a syringe configured to extract a bone marrow. The extracted bone marrow was washed, and red blood cells were then removed with ammonium chloride. The isolated cells were cultured at 37° C. for 8 days under a 5% CO2 atmosphere in a 6-well plate whose wells contained an RPMI 1640 medium (supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U / ml penicillin / streptomycin, 50 μM mercaptoethanol, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 20 ng / ml GM-CSF, and 20 ng / ml IL-4). GM-CSF and IL-4 were used to induce differentiation of the cells into dendritic cells.

[0045]1.2 Cloning of Recombinant ADK (Rv0733)

[0046]An ADK (Rv0733) region was amplified by a polymerase chain reaction (PCR) using the genomic DNA of Mycobacterium tuberculosis as a template (primers: 5′-CATATGAGAGT...

example 2

Analysis of Expression of Surface Molecules by ADK in Dendritic Cells

[0047]To determine an effect of ADK on expression of surface molecules in dendritic cells, this experiment was performed, as follows. Dendritic cells were treated respectively with ADK at concentrations of 1, 5 or 10 μg / ml or LPS at concentrations of 50 ng / ml for 24 hours, and then recovered. LPS was a substance known to promote the maturation of dendritic cells. To analyze the expression of the surface molecules in the dendritic cells, the dendritic cells were stained with cell surface molecule-specific antibodies such as anti-CD11c-FITC, anti-CD80-PE, anti-CD86-PE, anti-MHC I-PE, and anti-MHC II-PE antibodies for 30 minutes, and then washed with PBS. The stained dendritic cells were fixed in 4% paraformaldehyde, and analyzed using a flow cytometer FACSCalibur (Becton Dickinson, San Jose, Calif.). The results are shown in FIG. 2. As shown in FIG. 2, it was revealed that, when the dendritic cells were treated with ...

example 3

Analysis of Effect of ADK on Secretion of Cytokines in Dendritic Cells

[0048]To determine an effect of ADK on secretion of cytokines in dendritic cells, this experiment was performed, as follows. The dendritic cells were pre-treated with ADK at a concentration of 1, 5 or 10 μg / ml for an hour, treated with LPS at a concentration of 50 ng / ml for 24 hours, and the culture broth was recovered. Thereafter, the secretion levels of cytokines (TNF-α, IL-6, IL-1β, and IL-12 p70) were measured from the recovered culture broth using ELISA. The results are shown in FIG. 3.

[0049]As shown in FIG. 3, it was revealed that the secretion of the cytokines increased by LPS was reduced with an increasing concentration of ADK used for pretreatment of the dendritic cells.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Therapeuticaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a composition for preventing or treating sepsis or septic shock including a Mycobacterium tuberculosis-derived adenosine kinase (ADK) protein as an active ingredient. The Mycobacterium tuberculosis-derived ADK protein according to one exemplary embodiment of the present invention has an effect of inhibit binding between the LPS and cells by binding to LPS, and also has an excellent therapeutic effect against sepsis by enhancing viability in a sepsis animal model and suppressing inflammatory response in the lung and cell death in the spleen.

Description

TECHNICAL FIELD[0001]The present invention relates to a composition for preventing or treating sepsis or septic shock including an adenosine kinase (ADK) protein derived from Mycobacterium tuberculosis as an active ingredient.BACKGROUND ART[0002]Sepsis is an inflammatory response induced as a lipopolysaccharide (LPS) that is an ingredient of a cell wall acts as a toxin to activate the immune system in a living body excessively when the living body is infected with pathogenic gram-negative bacteria, and causes infections throughout the whole body or is often accompanied by shock when its symptoms are severe. Specifically, the sepsis often develops when hosts who are low resistant to humoral immunodeficiency or cellular immunodeficiency, such as patients, the aged, or premature babies who suffer from basal diseases such as malignant tumors, leukemia, malignant lymphoma, acquired immunodeficiency syndromes (AIDSs), collagen diseases, renal failure, liver diseases, cerebrovascular disor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/45
CPCA61K38/45A23V2002/00C12Y207/0102A23L1/034A23L29/06A61P11/00A61P29/00A61P31/04Y02A50/30
Inventor PARK, YEONG MINJUNG, IN DUKSHIN, SUNG JAEPARK, JUNG HEELEE, SEUNG JUNKANG, TAE HEUNGSOH, BYOUNG YUL
Owner KONKUK UNIV GLOCAL IND ACADEMIC COLLABORATION FOUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com